TF and lung carcinoma: The TF MAF has been considered as a risk factor (HR for bone metastasis = 2.5, 95% CI = 1.7 to 3.8, p < 0.001) in metastatic breast cancer (45) and as a checkpoint modulating macrophage in lung cancer (38).